Facio Therapies
PrivateLast Round
M&A
Apr 6, 2021
Est. Valuation
$11.8M
Total Funding Raised
$835,000
Company Overview
Facio Therapies operates in Healthcare & Life Sciences and is based in Leiden. Its latest recorded funding round was a Grant round in September 2020.
Facio Therapies is a biotechnology company focused on developing causal therapies to treat facioscapulohumeral muscular dystrophy (FSHD) by restoring the natural repression of the DUX4 protein.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
Nonprofit or NGO
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Facio Therapies Comparables
Compare Facio Therapies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Altay Therapeutics | 85% | |
| Myocea, Inc. | 84% | |
| Epicrispr Biotechnologies | 79% |
For institutional investors. Book with your work email.
Facio Therapies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Apr 6, 2021 | ||||
| Grant | Sep 1, 2020 | ||||
| Grant | Nov 1, 2018 | ||||
| VC Round | Jun 20, 2017 | ||||
| Grant | Nov 1, 2016 |
For institutional investors. Book with your work email.
Facio Therapies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| FSHD Canada Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 6, 2021
$12M raised from uniQure N.V.
- Sep 1, 2020
$380K grant from FSHD Canada Foundation received.
For institutional investors. Book with your work email.
Facio Therapies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Facio Therapies's valuation, stock price, and market status.
Is Facio Therapies a public or private company?
Facio Therapies is a private company.
What is the current stock price of Facio Therapies?
Facio Therapies is a private company, so its shares have no public market price. Caplight tracks Facio Therapies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Facio Therapies worth (valuation)?
Facio Therapies's valuation is estimated at $11.8M based on funding round data.
Can I buy Facio Therapies stock?
Facio Therapies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Facio Therapies's last funding round?
Facio Therapies's most recent funding round was M&A on April 6, 2021.
Who are the main investors in Facio Therapies?
Key investors in Facio Therapies include FSHD Canada Foundation.
Will Facio Therapies IPO soon?
No public IPO plans have been announced for Facio Therapies.
How can I track Facio Therapies secondary market activity?
Caplight tracks bids, offers, and trades in Facio Therapies's shares on secondary markets.